CATHERINE SINGISER: Open Payments
NPI 1265037717 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 15 payments from 7 companies in 2025. Trend: 2023 $34 · 2024 $614 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $93 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Daiichi Sankyo Inc. | 3 | $48 |
| PFIZER INC. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, INJECTAFER, VELSIPITY, MAVYRET, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
